What is Royalty Pharma Plc's ROA in the fourth quarter of 2023?
Royalty Pharma Plc achieved a return on average assets (ROA) of
58.61 % in its fourth quarter of 2023, this is above RPRX's average return on assets of -50.97%.
Royalty Pharma Plcs assets during the 12 months ending in the fourth quarter of 2023 are valued at $2 billion
ROA has improved compared to 11.72% in the third quarter of 2023, due to net income growth.
However, within the
Healthcare sector 41 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Dec 31 2023 quarter, so far to
430, from total ROA ranking in the third quarter of 2023 at
1787.
What is ROA?